A vaccination as tumor therapy—with a vaccine individually created from a patient's tissue sample that "attaches" the body's own immune system to cancer cells. The basis for this long-term vision has now been achieved by a team of researchers from the MPI for Polymer Research and the University Medical Center Mainz, in particular from the Departments of Immunology and Dermatology. Their results were recently published in the journal ACS Nano.